Theresa Boyle - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Theresa Boyle's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Theresa Boyle
Verified
Health Reporter, The (Toronto) Star
Toronto
Beats
Sports and music.
Content
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
By Subhamoy Chakraborty, Utsav Sen, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar, Avisek Banerjee, Hilal Özakinci, Elisa de Stanchina, Lewis E. Tomalin, Deniz Demircioğlu, Theresa Boyle Verified, Anna S. Tocheva, Dan Hasson, Triparna Sen, Kedwin Ventura, Yazhini Mahendravarman, Konrad Snioch| Cell Reports Medicine Verified Main text(Cell Reports Medicine 5, 101852; December 17, 2024)In the version of this article originally published, Figures 3A and 4G contained errors. Due to accidental error in figure preparation and transfer, the western blot panel of DMS114 in Figure 3A was a duplicate of the western blot panel of H69 in Figure S2B. The figures have now been corrected, and the correct DMS114 western blot panel has been updated in Figure 3A. The H69 western blot panel of Figure S2B remains the same.
They’re Ontario’s top-billing doctors, but for years their identities have been kept secret. Until now
By May Warren Verified, Theresa Boyle Verified| YorkRegion.com Verified He's Ontario's highest billing doctor: Narendra Armogan, an eye specialist with a bustling Mississauga practice, has charged the Ontario Health Insurance Plan an average of about $6 million a year, the Toronto Star can finally reveal. Armogan billed OHIP more than $42 million since 2011 for providing services and treatment to his patients, according to Ministry of Health data.
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
By Subhamoy Chakraborty, Utsav Sen, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar, Avisek Banerjee, Hilal Özakinci, Elisa de Stanchina, Lewis E. Tomalin, Deniz Demircioğlu, Theresa Boyle Verified, Anna S. Tocheva, Dan Hasson, Triparna Sen, Kedwin Ventura, Yazhini Mahendravarman, Konrad Snioch| Cell Reports Medicine Verified Main text(Cell Reports Medicine 5, 101852; December 17, 2024)In the version of this article originally published, Figures 3A and 4G contained errors. Due to accidental error in figure preparation and transfer, the western blot panel of DMS114 in Figure 3A was a duplicate of the western blot panel of H69 in Figure S2B. The figures have now been corrected, and the correct DMS114 western blot panel has been updated in Figure 3A. The H69 western blot panel of Figure S2B remains the same.
Company Info
The (Toronto) Star
Toronto, Canada